U.S. federal distribution channels, including mass vaccination sites, will pause the use of the Johnson & Johnson shot, and states and other providers are expected to follow
UPDATED: Regulators recommend suspension of Johnson & Johnson vaccines in U.S.
This development follows the suspension of usage of the Oxford AstraZeneca vaccine n various countries following similar issue.
The U.S. Centers for Disease Control and Prevention and the
US Food and Drug Administration have recommended that the United States pause the use of Johnson & Johnson’s Covid-19 vaccine over six reported U.S. cases of a “rare and severe” type of blood clot.
This six cases occurred among women aged 18 and 48, and symptoms occurred six to 13 days after vaccination, according to a joint statement on Tuesday from Anne Schuchat, principal deputy director of the CDC and Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research.
Manufacturer Johnson & Johnson suspends covid vaccine rollout amid blood clot concerns
UK Government has ordered 30 million doses but jab is yet to be approved
Updated (Image: Getty Images)
Sign up to the Hull Live newsletter for daily updates and breaking newsInvalid EmailSomething went wrong, please try again later.
Sign up here!
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice The manufacturer of a single-dose Covid-19 vaccine has suspended its roll out in Europe amid reports of blood clots.
Covid 19 coronavirus: US recommends pause for Johnson & Johnson vaccine over clot reports
13 Apr, 2021 11:27 AM
2 minutes to read
A member of the Philadelphia Fire Department administers the Johnson & Johnson Covid-19 vaccine to a person at a vaccination site. Photo / AP
A member of the Philadelphia Fire Department administers the Johnson & Johnson Covid-19 vaccine to a person at a vaccination site. Photo / AP
AP
By: Zeke Miller
The US is recommending a pause in administration of the single-dose Johnson & Johnson Covid-19 vaccine to investigate reports of potentially dangerous blood clots.
In a joint statement Tuesday, the Centres for Disease Control and Prevention and the Food and Drug Administration said it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts. More than 6.8 million doses of the J&J vaccine have been administered in the US.
US recommends pause for Johnson & Johnson Covid-19 vaccine over clot reports | Burnham and Highbridge Weekly News burnhamandhighbridgeweeklynews.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from burnhamandhighbridgeweeklynews.co.uk Daily Mail and Mail on Sunday newspapers.